Shareholders' equity · 2011–2025
Teva Pharmaceutical Industries shareholders' equity
$7.9B+47.2% · FY2025
Teva Pharmaceutical Industries (TEVA) reported $7.9B in shareholders' equity for fiscal 2025, +47.2% year on year.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $7.9B | +47.2% | Open → |
| FY20242024-12-31 | $5.4B | −28.4% | Open → |
| FY20232023-12-31 | $7.5B | −3.8% | Open → |
| FY20222022-12-31 | $7.8B | −24.1% | Open → |
| FY20212021-12-31 | $10.3B | +2.5% | Open → |
| FY20202020-12-31 | $10.0B | −28.2% | Open → |
| FY20192019-12-31 | $14.0B | −5.0% | Open → |
| FY20182018-12-31 | $14.7B | −15.3% | Open → |
| FY20172017-12-31 | $17.4B | −47.9% | Open → |
| FY20162016-12-31 | $33.3B | +12.0% | Open → |
| FY20152015-12-31 | $29.8B | +27.7% | Open → |
| FY20142014-12-31 | $23.3B | +3.3% | Open → |
| FY20132013-12-31 | $22.6B | −0.9% | Open → |
| FY20122012-12-31 | $22.8B | +2.6% | Open → |
| FY20112011-12-31 | $22.2B | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth −7.1%
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Teva Pharmaceutical Industries shareholders' equity |url=https://companiesranked.com/en/company/teva-pharmaceutical-industries/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Teva Pharmaceutical Industries shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/teva-pharmaceutical-industries/shareholders-equityBibTeX
@misc{companiesranked-en-company-teva-pharmaceutical-industries-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Teva Pharmaceutical Industries shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/teva-pharmaceutical-industries/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001193125-26-323619 · July 29, 2026
{{cite web |title=Teva Pharmaceutical Industries shareholders' equity — 10-Q (0001193125-26-323619) |url=https://www.sec.gov/Archives/edgar/data/818686/000119312526323619/d118828d10q.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-07-29}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.